SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006577
Filing Date
2018-08-07
Accepted
2018-08-07 16:02:33
Documents
65
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20180630x10q.htm 10-Q 2312160
2 EX-10.1 edit-20180630ex1014a6dfe.htm EX-10.1 814833
3 EX-10.2 edit-20180630ex102f1598a.htm EX-10.2 385420
4 EX-31.1 edit-20180630ex311fd1a03.htm EX-31.1 19695
5 EX-31.2 edit-20180630ex312277800.htm EX-31.2 19255
6 EX-32.1 edit-20180630ex32123f174.htm EX-32.1 13542
  Complete submission text file 0001558370-18-006577.txt   9360066

Data Files

Seq Description Document Type Size
7 EX-101.INS edit-20180630.xml EX-101.INS 1838404
8 EX-101.SCH edit-20180630.xsd EX-101.SCH 61634
9 EX-101.CAL edit-20180630_cal.xml EX-101.CAL 42623
10 EX-101.DEF edit-20180630_def.xml EX-101.DEF 196142
11 EX-101.LAB edit-20180630_lab.xml EX-101.LAB 478743
12 EX-101.PRE edit-20180630_pre.xml EX-101.PRE 341421
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 18997904
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences